U.S., Nov. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07931989) titled 'AI-Assisted Remote Monitoring for Patients With or at Risk of Malignant Bowel Obstruction' on Nov. 06.

Brief Summary: The goal of this clinical trial is to learn whether artificial intelligence (AI)-assisted remote symptom monitoring can reduce hospital admissions related to malignant bowel obstruction (MBO) in patients with advanced cancer who have MBO or are at risk of developing MBO.

The main questions it aims to answer are:

* Does AI-assisted remote symptom monitoring reduce the proportion of patients who experience at least one hospital admission due to MBO within 90 days?

* Does AI-assisted remote symptom monitoring improve...